Skip to main content

Advertisement

Log in

Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to assess the significance of the correlation among tissue carcinoembryonic antigen (CEA) expression with serum CEA (sCEA) levels and long-term survival to highlight the clinical prognostic significance of tissue CEA expression in gastric cancer patients.

Methods

Immunohistological method and radioimmunoassay were used to assess tissue and sCEA expression, respectively. Univariate and multivariate analyses were performed to determine correlations, and the Kaplan–Meier method was used to investigate the prognostic significance.

Results

Our results demonstrate that tissue CEA in gastric cancer is significantly correlated with preoperative sCEA levels (p = 0.031), depth of invasion (p = 0.001), lymph node metastasis (p < 0.001), distant metastasis (p = 0.001), and TNM staging (p < 0.001). The 5-year survival rates were 67.6, 53.9, and 40.1 % for negatively, moderately, and intensely positively stained tissues (p < 0.001), and 57.0 and 37.9 % for serum with normal and elevated CEA expression (p = 0.031). Multivariate analysis revealed that tissue CEA can be considered an independent prognostic factor. Further analysis illustrated that patients with negative expression in both tissue and serum had better prognosis compared with those positively expressing CEA in both tissue and serum and/or those positively expressing CEA in either tissue or serum (p < 0.001). Our results also demonstrated that patients with negative tissue CEA staining and elevated sCEA expression had a better 5-year survival.

Conclusion

Tissue CEA expression in gastric cancer is directly correlated with sCEA levels and long-term prognosis. Thus, tissue CEA expression can be considered as a useful biomarker to improve the interpretation of sCEA levels in predicting long-term survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137–50.

    Article  PubMed  Google Scholar 

  2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

    Article  PubMed  Google Scholar 

  3. Lim JS, Yun MJ, Kim MJ, et al. CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics. 2006;26(1):143–56.

    Article  PubMed  Google Scholar 

  4. Posner MR, Mayer RJ. The use of serologic tumor markers in gastrointestinal malignancies. Hematol Oncol Clin N Am. 1994;8(3):533–53.

    CAS  Google Scholar 

  5. Takahashi Y, Takeuchi T, Sakamoto J, et al. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer. 2003;6(3):142–5.

    Article  PubMed  Google Scholar 

  6. Thompson J, Zimmermann W, Osthus-Bugat P, et al. Long-range chromosomal mapping of the carcinoembryonic antigen (CEA) gene family cluster. Genomics. 1992;12(4):761–72.

    Article  CAS  PubMed  Google Scholar 

  7. Tamada R, Hiramoto Y, Tsujitani S, et al. Serum CEA levels facilitate detection of recurrences of cancer in patients after gastrectomy. Jpn J Surg. 1985;15(1):23–9.

    Article  CAS  PubMed  Google Scholar 

  8. Park SH, Ku KB, Chung HY, Yu W. Prognostic significance of serum and tissue carcinoembryonic antigen in patients with gastric adenocarcinomas. Cancer Res Treat. 2008;40(1):16–21.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Bhatnagar J, Heroman W, Murphy M, Austin GE. Immunohistochemical detection of carcinoembryonic antigen in esophageal carcinomas: a comparison with other gastrointestinal neoplasms. Anticancer Res. 2002;22(3):1849–57.

    CAS  PubMed  Google Scholar 

  10. Nazato DM, Matos LL, Waisberg DR, Souza JR, Martins LC, Waisberg J. Prognostic value of carcinoembryonic antigen distribution in tumor tissue of colorectal carcinoma. Arq Gastroenterol. 2009;46(1):26–31.

    Article  PubMed  Google Scholar 

  11. Okamura A, Ohkawa J, Fujisawa H, Sashikata T. Clinicopathological study on the relationship between serum-CEA and tissue-CEA of resected lung cancer cases. Acta Pathol Jpn. 1984;34(6):1209–19.

    CAS  PubMed  Google Scholar 

  12. Michaelidou K, Tzovaras A, Missitzis I, Ardavanis A, Scorilas A. The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression. Int J Oncol. 2013;42(5):1770–77.

    CAS  PubMed  Google Scholar 

  13. Han CP, Lee MY, Kok LF, et al. A reappraisal of three-marker (ER/Vim/CEA), four-marker (ER/Vim/CEA/PR), and five-marker (ER/Vim/CEA/PR/p16INK4a) panels in the diagnostic distinction between primary endocervical and endometrial adenocarcinomas in a tissue microarray study. Arch Gynecol Obstet. 2010;281(5):845–50.

    Article  CAS  PubMed  Google Scholar 

  14. Smithson JE, Warren BF, Young S, Pigott R, Jewell DP. Heterogeneous expression of carcinoembryonic antigen in the normal colon and upregulation in active ulcerative colitis. J Pathol. 1996;180(2):146–51.

    Article  CAS  PubMed  Google Scholar 

  15. Isaacson P, Judd MA. Carcinoembryonic antigen (CEA) in the normal human small intestine: a light and electron microscopic study. Gut. 1977;18(10):786–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Bunn PA Jr, Cohen MI, Widerlite L, Nugent JL, Matthews MJ, Minna JD. Simultaneous gastric and plasma immunoreactive plasma carcinoembryonic antigen in 108 patients undergoing gastroscopy. Gastroenterology. 1979;76(4):734–41.

    PubMed  Google Scholar 

  17. Charalabopoulos K, Kotsalos A, Batistatou A, et al. Serum and tissue selenium levels in gastric cancer patients and correlation with CEA. Anticancer Res. 2009;29(8):3465–67.

    CAS  PubMed  Google Scholar 

  18. Kojima O, Ikeda E, Uehara Y, Majima T, Fujita Y, Majima S. Correlation between carcinoembryonic antigen in gastric cancer tissue and survival of patients with gastric cancer. Gan. 1984;75(3):230–36.

    CAS  PubMed  Google Scholar 

  19. Nishida H. Immunohistochemical localization of carcinoembryonic antigen (CEA) in gastric cancer–a comparative study between tissue CEA and plasma CEA [in Japanese]. Nihon Geka Gakkai Zasshi. 1983;84(4):328–35.

    CAS  PubMed  Google Scholar 

  20. Rosandić-Pilas M, Hadzic N, Stavljenic A, Juricic M, Scukanec-Spoljar M. Relationship between tissue and serum concentrations of carcinoembryonic antigen (CEA) in gastric and colonic carcinomas. Acta Med Austriaca. 1990;17(5):89–93.

    PubMed  Google Scholar 

  21. Lee JC, Lee SY, Kim CY, Yang DH. Clinical utility of tumor marker cutoff ratio and a combination scoring system of preoperative carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4 levels in gastric cancer. J Korean Surg Soc. 2013;85(6):283–89.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Zhou H, Stanners CP, Fuks A. Specificity of anti-carcinoembryonic antigen monoclonal antibodies and their effects on CEA-mediated adhesion. Cancer Res. 1993;53(16):3817–22.

    CAS  PubMed  Google Scholar 

  23. Beauchemin N, Draber P, Dveksler G, et al. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res. 1999;252(2):243–49.

    Article  CAS  PubMed  Google Scholar 

  24. Bjerner J, Lebedin Y, Bellanger L, et al. Protein epitopes in carcinoembryonic antigen. Report of the ISOBM TD8 workshop. Tumour Biol. 2002;23(4):249–62.

    Article  CAS  PubMed  Google Scholar 

  25. Chiquillo Barber MT, Bort Marti I, Navarro Fos S, Perez Bacete M, Esclapez Valero J, Gomez-Ferrer Bayo F. A correlation between serum levels of preoperative CEA and CEA immunohistochemical staining in colorectal carcinoma [in Spanish]. Rev Esp Enferm Dig. 1993;83(4):249–54.

    PubMed  Google Scholar 

  26. Hammarstrom S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol. 1999;9(2):67–81.

    Article  CAS  PubMed  Google Scholar 

  27. Burtin P, von Kleist S, Sabine MC, King M. Immunohistological localization of carcinoembryonic antigen and nonspecific cross-reacting antigen in gastrointestinal normal and tumoral tissues. Cancer Res. 1973;33(12):3299–305.

    CAS  PubMed  Google Scholar 

  28. Ikeda Y, Mori M, Kamakura T, Haraguchi Y, Saku M, Sugimachi K. Increased incidence of undifferentiated type of gastric cancer with tumor progression in 912 patients with early gastric cancer and 1245 with advanced gastric cancer. Cancer. 1994;73(10):2459–63.

    Article  CAS  PubMed  Google Scholar 

  29. Kodera Y, Isobe K, Yamauchi M, et al. Expression of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA) in gastrointestinal cancer; the correlation with degree of differentiation. Br J Cancer. 1993;68(1):130–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Imamura T, Komatsu S, Ichikawa D, et al. Poor prognostic subgroup in T3N0 stage IIA gastric cancer, suggesting an indication for adjuvant chemotherapy. J Surg Oncol. 2015;111(2):221–25.

    Article  PubMed  Google Scholar 

  31. Takahari D, Hamaguchi T, Yoshimura K, et al. Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer. Gastric Cancer. 2014;17(2):383–386.

    Article  CAS  PubMed  Google Scholar 

  32. Min C, Bangalore S, Jhawar S, et al. Chemoradiation therapy versus chemotherapy alone for gastric cancer after R0 surgical resection: a meta-analysis of randomized trials. Oncology. 2014;86(2):79–85.

    Article  CAS  PubMed  Google Scholar 

  33. Stessin AM, Sison C, Schwartz A, Ng J, Chao CK, Li B. Does adjuvant radiotherapy benefit patients with diffuse-type gastric cancer? Results from the surveillance, epidemiology, and end results database. Cancer. 2014;120(22):3562–68.

    Article  PubMed  Google Scholar 

  34. Foo M, Crosby T, Rackley T, Leong T. Role of (chemo)-radiotherapy in resectable gastric cancer. Clin Oncol (R Coll Radiol). 2014;26(9):541–50.

    Article  CAS  PubMed  Google Scholar 

  35. Lordick F, Lorenzen S, Yamada Y, Ilson D. Optimal chemotherapy for advanced gastric cancer: is there a global consensus? Gastric Cancer. 2014;17(2):213–25.

    Article  CAS  PubMed  Google Scholar 

  36. Oh DY, Bang YJ. Adjuvant and neoadjuvant therapy for gastric cancer. Curr Treat Options Oncol. 2013;14(3):311–20.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

Work on this article was supported in part by the National Natural Science Foundation of China (Grant Nos. 81172080, 81201773, and 81411130217), the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20120171120114), the Science and Technology Projects of Guangdong Province (Grant No. 2011B031800181), and the National High-Tech R&D Program [863 Program] (Grant No. 2012AA02A504).

Disclosures

Wei Wang, Sharvesh Raj Seeruttun, Cheng Fang, Jiewei Chen, Yong Li, Zhimin Liu, Youqing Zhan, Wei Li, Yingbo Chen, Xiaowei Sun, Yuanfang Li, Dazhi Xu, Yuanxiang Guan, and Zhiwei Zhou have no conflicts or financial interests to be declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhiwei Zhou MD, PhD.

Additional information

Wei Wang, Sharvesh Raj Seeruttun, and Cheng Fang have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, W., Seeruttun, S.R., Fang, C. et al. Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients. Ann Surg Oncol 23, 1244–1251 (2016). https://doi.org/10.1245/s10434-015-4981-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-015-4981-6

Keywords

Navigation